Soaring prescription drug prices are putting financial pressure on families across the country. In response, state legislators are increasingly considering limits on the annual price increase of prescription drugs. But rather than making drugs more affordable, these policies risk reducing consumer access to cheaper, generic alternatives. Read this op-ed in The Hill […]
The Trump administration’s recent efforts to increase transparency in hospital pricing have expectedly been met with legal push-back from the hospitals themselves. But shadowy hospital pricing is just the tip of the opaque iceberg that is driving up the costs of health care in America. To inject more competition into the industry, Congress and the […]
Action must be taken by health insurance companies to protect and work in the interest of their clients. We need price transparency in the healthcare market. In many cases consumers who have insurance are asked to sign a waiver that makes them responsible for any charge later found not to be covered by their insurance […]
The legislature recently banned all flavored e-cigarettes in the state while also instituting a 75 percent excise tax on the product — the highest in the nation. While the law was passed under the guise of protecting teen health, the only thing it has accomplished is making e-cigarettes more dangerous. You can read this op-ed […]
Over 480,000 people annually lose their lives due to cigarettes, while 34 million Americans smoke every year. As the new commission at the FDA, it is his responsibility to ensure the public has access to products that reduce harm and promote health. E-cigarettes are an essential product that have already saved lives and continue to help […]
Politicians seeking to punish consumers for buying sugary drinks have seized upon a convenient scapegoat, but they have ignored principles of sound tax policy. The D.C. Council should learn the lessons of the past. You can read this op-ed by visiting The Hill.
Today, ACI, along with 75 organizations and activists, sent a letter to Congress opposing Medicare-for-All legislation that includes provisions for the government to set prescription prices. The letter is available online.
Professors Fuhr and Blackstone, both senior fellows at ACI, published an article on biologic drugs for the Center for Biosimilars. The article is available online.
Senator and presidential-hopeful Elizabeth Warren (D-Ma) has made headlines in recent weeks by releasing the details of how she would fund her vision of Medicare-for-All. But far from the headlines, and hidden deep in her 9,000 word blueprint, lies her plan to put a stop to American medical innovation. By strong-arming innovators and removing all […]
Today, ACI joined twenty-two other nonprofits in support of legislation that would reduce the cost of medications by providing Medicare patients access to lower-cost generic drugs and biosimilars. The letter is available online.